BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6228469)

  • 1. Efficacy trial of heat-inactivated hepatitis B vaccine (CLB) in male homosexuals in the Netherlands.
    Coutinho RA; Lelie PN; Albrecht-van Lent P; Stoutjesdijk L; Huisman J; Kuipers H; Schut LJ; Reerink-Brongers EE; Reesink HW; van Aken WG
    Dev Biol Stand; 1983; 54():287-92. PubMed ID: 6228469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of heat-inactivated hepatitis B vaccine (CLB) in low risk human volunteers and in patients treated with chronic haemodialysis in the Netherlands.
    Reerink-Brongers EE; Lelie PN; Reesink HW; Dees PJ; Brummelhuis HG; van Aken WG
    Dev Biol Stand; 1983; 54():197-203. PubMed ID: 6228459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.
    Szmuness W; Stevens CE; Harley EJ; Zang EA; Oleszko WR; William DC; Sadovsky R; Morrison JM; Kellner A
    N Engl J Med; 1980 Oct; 303(15):833-41. PubMed ID: 6997738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine: clinical trials in high-risk settings in France. (September 1975-September 1982).
    Goudeau A; Dubois F; Barin F; Dubois MC; Coursaget P
    Dev Biol Stand; 1983; 54():267-84. PubMed ID: 6228468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial.
    Coutinho RA; Lelie N; Albrecht-Van Lent P; Reerink-Brongers EE; Stoutjesdijk L; Dees P; Nivard J; Huisman J; Reesink HW
    Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1305-8. PubMed ID: 6404440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B in haemodialysis: vaccination against HBS antigen.
    Crosnier J
    Proc Eur Dial Transplant Assoc; 1981; 18():231-40. PubMed ID: 7036150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of low dose intradermal hepatitis B vaccine: results of a randomized trial among health care workers.
    Das HS; Sawant P; Shirhatti RG; Vyas K; Vispute S; Dhadphale S; Patrawalla V; Desai N
    Trop Gastroenterol; 2002; 23(3):120-1. PubMed ID: 12693152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
    Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
    IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccine: safety study in anti-HBs seronegative human volunteers.
    Kaufmann R; Mondorf AW; Uthemann H; Bauer H; Prince AM
    Dev Biol Stand; 1983; 54():229-35. PubMed ID: 6228463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine].
    Xia G; Jia Z; Yan T; Li R; Liu H; Xu Z; Cao H; Liu C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):146-9. PubMed ID: 12196826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of hepatitis B vaccine in susceptible spouses of chronic hepatitis B virus infected individuals at the time of marriage.
    Roushan MR; Samie H; Amiri MJ
    Saudi Med J; 2007 Apr; 28(4):540-3. PubMed ID: 17457474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of acute hepatitis B in homosexual men to chronic hepatitis B. Prospective study of placebo recipients in a hepatitis B vaccine trial.
    Shah N; Ostrow D; Altman N; Baker AL
    Arch Intern Med; 1985 May; 145(5):881-2. PubMed ID: 3158291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
    Xu H; Zuo H; Zhuang G
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):205-7. PubMed ID: 10322755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active hepatitis B immunization with an experimental German vaccine. I. Immunogenicity studies in healthy adults. II. The primary 19 S and 7 S responses to HBsAg in healthy adults. III. Immunogenicity studies in hemodialysis patients.
    Scheiermann N; Kuwert EK
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):439-55. PubMed ID: 6485639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.